The Oncology Institute, Inc. TOI Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s financing cash flow?
- The Oncology Institute, Inc. (TOI) reported financing cash flow of -$28K in Q1 2026.
- How has The Oncology Institute, Inc.'s financing cash flow changed year-over-year?
- The Oncology Institute, Inc.'s financing cash flow increased by 99.4% year-over-year, from -$4.74M to -$28K.
- What is the long-term trend for The Oncology Institute, Inc.'s financing cash flow?
- Over 3 years (2022 to 2025), The Oncology Institute, Inc.'s financing cash flow has grown at a -50.1% compound annual growth rate (CAGR), from $93.05M to $11.56M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.